The Use of CD44 Variant 9 and Ki-67 Combination Can Predicts Prognosis Better Than Their Single Use in Early Gastric Cancer

PURPOSE: We previously demonstrated that CD44v9 and Ki-67 played an important role in predicting poor prognosis of early gastric cancer (EGC). However, little is known about combined use of both biomarkers as prognostic biomarker. The present study was performed to investigate the significance of CD...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cancer Res Treat
Asıl Yazarlar: Go, Se-Il, Ko, Gyung Hyuck, Lee, Won Sup, Lee, Jeong-Hee, Jeong, Sang-Ho, Lee, Young-Joon, Hong, Soon Chan, Ha, Woo Song
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Korean Cancer Association 2019
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6790844/
https://ncbi.nlm.nih.gov/pubmed/30913874
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2018.663
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller